Sempra
SRE | NYSE
$86.19
+$0.13 (+0.15%)
Nov 2, 2026, 1:17 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 13.71B | 12.96B | 15.8B | 15.55B | 13.06B | 11.35B |
Cost of Revenue | 9.72B | 9.43B | 12.06B | 11.39B | 9.42B | 8.08B |
Gross Profit | 4B | 3.52B | 3.75B | 4.16B | 3.64B | 3.28B |
Operating Income | 3.25B | 2.83B | 3.07B | 3.53B | 3.05B | 2.74B |
Interest Income | 103M | 61M | 89M | 75M | 69M | 96M |
Pretax Income | 2.77B | 3.72B | 4.11B | 2.84B | 1.56B | 2.5B |
Net Income | 1.84B | 2.86B | 3.08B | 2.14B | 1.32B | 3.93B |
Selling & General & Admin | 744M | 693M | 677M | 635M | 596M | 543M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 744M | 693M | 677M | 635M | 596M | 543M |
Interest Expense | 1.53B | 1.3B | 1.26B | 1.06B | 1.19B | 1.07B |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 10.46B | 10.13B | 12.73B | 12.03B | 10.01B | 8.62B |
Income Tax Expense | 701M | 219M | 490M | 556M | 99M | 249M |
Shares Outstanding (Basic) | 652.7M | 633.8M | 630.3M | 630.32M | 623.51M | 582.15M |
Shares Outstanding (Diluted) | 652.7M | 637.94M | 632.73M | 632.76M | 626.07M | 584.5M |
EPS (Basic) | 2.75 | 4.44 | 4.81 | 3.32 | 2.01 | 6.47 |
EPS (Diluted) | 2.75 | 4.42 | 4.79 | 3.31 | 2 | 6.44 |
EBITDA | 6.87B | 5.85B | 6.12B | 4.42B | 3.26B | 4.23B |
EBIT | 4.31B | 3.41B | 3.89B | 2.4B | 1.41B | 2.56B |
Depreciation & Amortization | 2.56B | 2.44B | 2.23B | 2.02B | 1.86B | 1.67B |
Add to Watchlist
Select watchlists to add or remove SRE